Torrent Pharmaceuticals Q2 FY27: PAT ₹100.2 Cr

Metric	Value
Net Profit (PAT)	₹100.2 Cr

📢 Key Event
Conference call transcript released for Q1 FY26 financial results

💡 Investor Takeaway
Review the transcript for insights into quarterly performance and management outlook.

Torrent Pharmaceuticals announced a conference call transcript for Q1 FY26 results on August 4, 2026, inviting analysts and institutional investors to review the discussion on financial performance and future outlook.

📄 View Original Announcement (PDF)

📊 Stock Analysis — TORNTPHARM ✨ Ask AI About This

About Torrent Pharmaceuticals Limited (TORNTPHARM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,49,108.91 Cr P/E: 80.1

View full TORNTPHARM stock details →

📡 Get AI alerts when TORNTPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track TORNTPHARM — Free

💡 Ask AI about this filing

"What were the key financial metrics discussed?" "How does management view FY26 growth prospects?" "Which risks were highlighted for the pharma sector?"

Ask AI Free →

📊 More TORNTPHARM filings

See all TORNTPHARM filings →

🔥 Also filed on 4 August 2026

UNIMECH Unimech Aerospace and Manufacturing Limited Annual Report VRLLOG VRL Logistics Limited Financial Results EMAMILTD Emami Limited Financial Results WORTHPERI Worth Peripherals Limited Financial Results PRICOLLTD Pricol Limited Financial Results JYOTISTRUC Jyoti Structures Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when TORNTPHARM files new disclosures

Track TORNTPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.